SCHEMBL9811098

SCHEMBL9811098

O=C1NC(=O)C2(N1)c1cc([N+](=O)[O-])ccc1-c1ccc([N+](=O)[O-])cc12

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 12/20 0.58
▸ AKR1A1 P14550 10/20 0.58
▸ ITGA4 P13612 1/20 0.51
▸ CYP3A4 P08684 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ TDP2 O95551 1/20 0.47
▸ PTPRC P08575 1/20 0.46
▸ S100A4 P26447 1/20 0.46
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ CA7 P43166 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ CAPN9 O14815 1/20 0.43
▸ CASP3 P42574 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9810966 0.93 ITGA4 (0.65) AKR1B1AKR1A1ITGA4CYP3A4TDP1
SCHEMBL9671858 0.84 TDP1 (0.49) AKR1B1AKR1A1ITGA4CYP3A4TDP1
SCHEMBL27233049 0.77 ALDH1A1 (0.56) AKR1B1ITGA4CYP3A4TDP1ALDH1A1
SCHEMBL9811003 0.73 AKR1A1 (0.65) AKR1B1AKR1A1ITGA4ALDH1A1
SCHEMBL22380780 0.73 AKR1B1 (0.65) AKR1B1AKR1A1ITGA4ALDH1A1
Imirestat SCHEMBL30924520 0.73 AKR1A1 (1.00) AKR1B1AKR1A1ITGA4
Imirestat SCHEMBL49034 0.73 AKR1A1 (1.00) AKR1B1AKR1A1ITGA4
SCHEMBL11001789 0.73 AKR1B1 (1.00) AKR1B1AKR1A1ITGA4
SCHEMBL12282222 0.72 PTPRC (0.53) CYP3A4TDP1TDP2PTPRCS100A4
SCHEMBL24193439 0.72 MAPT (0.69) AKR1B1ITGA4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0092385-B1 HYDANTOIN DERIVATIVES FOR USE IN INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOREN COMPOUNDS ALCON LABORATORIES, INC. (US) 1991-06-12 — — EP disclosed
US-4540700-A Treatment of diabetic complications with certain spiro-imidazolidine-diones ALCON LABORATORIES, INC. (US) 1985-09-10 — — US disclosed
US-4436745-A TETRACYCLIC SPIROHYDANTOINS ALCON LABORATORIES, INC. (US) 1984-03-13 — — US disclosed
WO-1983003543-A1 METHOD OF INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOROFLUOREN AND SPIRO-DIFLUOROFLUOREN COMPOUNDS ALCON LAB INC (US) 1983-10-27 — — WO disclosed
Send feedback